Equillium Valuation
| EQ Stock | USD 1.81 0.09 5.23% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Equillium shows a prevailing Real Value of $1.81 per share. The current price of the firm is $1.81. Our model computes the value of Equillium from reviewing the firm fundamentals such as Shares Outstanding of 35.25 M, current valuation of 20.6 M, and Profit Margin of (0.37) % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Equillium's valuation include:
Price Book 2.9518 | Enterprise Value 20.6 M | Enterprise Value Ebitda (2.19) | Price Sales 1.8075 | Forward PE 3.4364 |
Undervalued
Today
Please note that Equillium's price fluctuation is abnormally volatile at this time. Calculation of the real value of Equillium is based on 3 months time horizon. Increasing Equillium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Equillium is useful when determining the fair value of the Equillium stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Equillium. Since Equillium is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Equillium Stock. However, Equillium's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.81 | Real 1.81 | Target 8.0 | Hype 1.72 |
The real value of Equillium Stock, also known as its intrinsic value, is the underlying worth of Equillium Company, which is reflected in its stock price. It is based on Equillium's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Equillium's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Equillium's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Equillium helps investors to forecast how Equillium stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Equillium more accurately as focusing exclusively on Equillium's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Equillium's intrinsic value based on its ongoing forecasts of Equillium's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Equillium's closest peers. When choosing an evaluation method for Equillium, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Equillium Investments |
|
Equillium Valuation Trend
Knowing Equillium's actual value is paramount for traders to make sound investment determinations. Equillium's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Equillium's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Equillium's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Equillium Market Cap
Equillium is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 4.68 Billion. Equillium claims roughly 60.64 Million in market capitalization contributing just under 2% to equities under Health Care industry.Equillium Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Equillium's current stock value. Our valuation model uses many indicators to compare Equillium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Equillium competition to find correlations between indicators driving Equillium's intrinsic value. More Info.Equillium is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . As of 04/24/2024, Price To Book Ratio is likely to grow to 1.53. Comparative valuation analysis is a catch-all model that can be used if you cannot value Equillium by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Equillium's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Equillium's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Equillium's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Equillium and how it compares across the competition.
About Equillium Valuation
The stock valuation mechanism determines the current worth of Equillium on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Equillium. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Equillium based exclusively on its fundamental and basic technical indicators. By analyzing Equillium's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Equillium's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Equillium. We calculate exposure to Equillium's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Equillium's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 36 M | 37.8 M | |
| Pretax Profit Margin | (0.35) | (0.37) | |
| Operating Profit Margin | (0.40) | (0.42) | |
| Net Loss | (0.37) | (0.39) | |
| Gross Profit Margin | 1.00 | 0.79 |
8 Steps to conduct Equillium's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Equillium's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Equillium's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Equillium's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Equillium's revenue streams: Identify Equillium's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Equillium's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Equillium's growth potential: Evaluate Equillium's management, business model, and growth potential.
- Determine Equillium's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Equillium's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Equillium Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Equillium does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 34.7 M | |
| Forward Price Earnings | 3.4364 |
Equillium Current Valuation Indicators
Valuation refers to the process of determining the present value of Equillium and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Equillium we look at many different elements of the entity such as Equillium's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Equillium's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Equillium's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Equillium, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Equillium's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Equillium's worth.When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Equillium Stock analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Revenue Per Share 1.039 | Quarterly Revenue Growth (0.42) | Return On Assets (0.14) | Return On Equity (0.49) |
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.